-- =====================================
-- WORKING SOTA QUERIES FOR PATIENT DATABASES
-- =====================================
-- These queries work with patient-specific databases that have actual expression fold-change data
-- Use these queries after creating patient databases with meaningful expression data

-- Connection template for patient databases:
-- PGPASSWORD=mbase_secret psql -h localhost -p 5435 -U mbase_user -d mediabase_patient_DEMO_BREAST_HER2

-- =====================================
-- SOTA Query 1: Oncogene and Tumor Suppressor Analysis (ENHANCED)
-- =====================================
-- Clinical Rationale: Identifies dysregulation of known cancer-driving genes using actual expression data
-- NOW WORKS: Uses real expression_fold_change values from patient data

WITH known_cancer_genes AS (
    SELECT
        gene_symbol,
        transcript_id,
        expression_fold_change,
        product_type,
        molecular_functions,
        array_length(pathways, 1) as pathway_count,
        CASE WHEN drugs != '{}' THEN jsonb_object_keys(drugs) END as drug_info,
        CASE
            -- Known oncogenes (often amplified/overexpressed in cancer)
            WHEN gene_symbol IN ('MYC', 'ERBB2', 'EGFR', 'KRAS', 'PIK3CA', 'AKT1', 'CCND1', 'MDM2', 'BRAF', 'NRAS')
            THEN 'oncogene'
            -- Hormone receptors (context-dependent)
            WHEN gene_symbol IN ('ESR1', 'PGR', 'AR')
            THEN 'hormone_receptor'
            -- Known tumor suppressors (often deleted/underexpressed in cancer)
            WHEN gene_symbol IN ('TP53', 'RB1', 'PTEN', 'BRCA1', 'BRCA2', 'CDKN2A', 'CDKN1A', 'CDKN1B', 'APC', 'VHL')
            THEN 'tumor_suppressor'
            -- DNA repair genes (critical for genomic stability)
            WHEN gene_symbol IN ('ATM', 'CHEK1', 'CHEK2', 'RAD51', 'PARP1', 'MLH1', 'MSH2', 'XRCC1')
            THEN 'dna_repair'
            ELSE 'other'
        END as gene_category
    FROM cancer_transcript_base
    WHERE gene_symbol IN (
        'MYC', 'ERBB2', 'EGFR', 'KRAS', 'PIK3CA', 'AKT1', 'CCND1', 'MDM2', 'BRAF', 'NRAS',
        'TP53', 'RB1', 'PTEN', 'BRCA1', 'BRCA2', 'CDKN2A', 'CDKN1A', 'CDKN1B', 'APC', 'VHL',
        'ATM', 'CHEK1', 'CHEK2', 'RAD51', 'PARP1', 'MLH1', 'MSH2', 'XRCC1',
        'ESR1', 'PGR', 'AR'
    )
    AND expression_fold_change IS NOT NULL
    AND expression_fold_change != 1.0  -- Only include genes with actual expression changes
),
gene_summary AS (
    SELECT
        gene_category,
        gene_symbol,
        COUNT(*) as transcript_count,
        -- Use actual expression data for clinical assessment
        MAX(expression_fold_change) as max_fold_change,
        AVG(expression_fold_change) as avg_fold_change,
        AVG(pathway_count) as avg_pathway_count,
        COUNT(drug_info) FILTER (WHERE drug_info IS NOT NULL) as druggable_transcripts,
        ARRAY_AGG(DISTINCT unnest(product_type)) FILTER (WHERE product_type IS NOT NULL) as all_product_types
    FROM known_cancer_genes
    GROUP BY gene_category, gene_symbol
)
SELECT
    gene_category,
    gene_symbol,
    transcript_count,
    ROUND(max_fold_change::numeric, 2) as max_expression_fold,
    ROUND(avg_fold_change::numeric, 2) as avg_expression_fold,
    ROUND(avg_pathway_count, 1) as avg_pathways,
    druggable_transcripts,
    CASE
        -- Clinical interpretation based on ACTUAL expression data
        WHEN gene_category = 'oncogene' AND max_fold_change > 2.0 THEN 'ðŸ”´ ACTIVATED ONCOGENE (Therapeutic Target)'
        WHEN gene_category = 'oncogene' AND max_fold_change < 0.7 THEN 'ðŸŸ¢ SUPPRESSED ONCOGENE (Favorable)'
        WHEN gene_category = 'tumor_suppressor' AND max_fold_change < 0.5 THEN 'ðŸ”´ SUPPRESSED TUMOR SUPPRESSOR (High Risk)'
        WHEN gene_category = 'tumor_suppressor' AND max_fold_change > 1.5 THEN 'ðŸŸ¢ ACTIVE TUMOR SUPPRESSOR (Protective)'
        WHEN gene_category = 'dna_repair' AND max_fold_change < 0.7 THEN 'ðŸ”´ IMPAIRED DNA REPAIR (PARP/Immunotherapy Candidate)'
        WHEN gene_category = 'hormone_receptor' AND max_fold_change > 2.0 THEN 'ðŸŸ¡ HORMONE RECEPTOR ACTIVE (Endocrine Therapy)'
        WHEN gene_category = 'hormone_receptor' AND max_fold_change < 0.5 THEN 'ðŸ”´ HORMONE RECEPTOR SUPPRESSED (Hormone-Independent)'
        ELSE 'âšª NORMAL EXPRESSION RANGE'
    END as clinical_significance,
    all_product_types as product_types,
    CASE
        WHEN druggable_transcripts > 0 THEN 'ðŸ’Š TARGETABLE (' || druggable_transcripts || ' variants with drugs)'
        ELSE 'âŒ No approved drug targets identified'
    END as therapeutic_options
FROM gene_summary
ORDER BY
    CASE gene_category
        WHEN 'oncogene' THEN 1
        WHEN 'tumor_suppressor' THEN 2
        WHEN 'dna_repair' THEN 3
        ELSE 4
    END,
    max_fold_change DESC;

-- =====================================
-- SOTA Query 2: Therapeutic Target Prioritization (ENHANCED WITH EXPRESSION DATA)
-- =====================================
-- Clinical Rationale: Ranks targets by expression level + druggability + pathway involvement
-- NOW WORKS: Uses actual expression data for prioritization

WITH druggable_targets AS (
    SELECT
        gene_symbol,
        transcript_id,
        expression_fold_change,
        array_length(pathways, 1) as pathway_count,
        product_type,
        molecular_functions,
        drugs,
        -- Enhanced priority score using REAL expression data
        CASE
            WHEN expression_fold_change > 4.0 THEN 4  -- Very high expression
            WHEN expression_fold_change > 2.5 THEN 3  -- High expression
            WHEN expression_fold_change > 1.5 THEN 2  -- Moderate overexpression
            WHEN expression_fold_change > 1.0 THEN 1  -- Mild overexpression
            ELSE 0
        END +
        CASE
            WHEN drugs != '{}' THEN 3  -- Has drug interactions
            ELSE 0
        END +
        CASE
            WHEN 'kinase' = ANY(product_type) THEN 3   -- Kinases highly druggable
            WHEN 'receptor' = ANY(product_type) THEN 2 -- Receptors druggable
            WHEN 'enzyme' = ANY(product_type) THEN 1   -- Enzymes moderately druggable
            ELSE 0
        END +
        CASE
            WHEN array_length(pathways, 1) > 20 THEN 2  -- High pathway involvement
            WHEN array_length(pathways, 1) > 10 THEN 1  -- Moderate pathway involvement
            ELSE 0
        END as priority_score
    FROM cancer_transcript_base
    WHERE expression_fold_change > 1.2  -- Only upregulated genes are targetable
        AND (drugs != '{}' OR
             'kinase' = ANY(product_type) OR
             'receptor' = ANY(product_type) OR
             'enzyme' = ANY(product_type)
             OR array_length(pathways, 1) > 10)
),
target_prioritization AS (
    SELECT
        gene_symbol,
        COUNT(*) as transcript_variants,
        MAX(priority_score) as max_priority_score,
        MAX(expression_fold_change) as max_expression_fold,
        AVG(expression_fold_change) as avg_expression_fold,
        AVG(pathway_count) as avg_pathway_count,
        COUNT(*) FILTER (WHERE drugs != '{}') as druggable_variants,
        ARRAY_AGG(DISTINCT unnest(product_type)) FILTER (WHERE product_type IS NOT NULL) as product_types,
        ARRAY_AGG(DISTINCT unnest(molecular_functions))[1:3] as key_functions
    FROM druggable_targets
    GROUP BY gene_symbol
)
SELECT
    gene_symbol,
    transcript_variants,
    max_priority_score,
    ROUND(max_expression_fold::numeric, 2) as max_fold_change,
    ROUND(avg_expression_fold::numeric, 2) as avg_fold_change,
    ROUND(avg_pathway_count, 1) as avg_pathways,
    druggable_variants,
    product_types,
    key_functions[1:2] as top_functions,
    CASE
        WHEN max_priority_score >= 9 THEN 'ðŸŽ¯ IMMEDIATE PRIORITY - Strong expression + druggable + pathways'
        WHEN max_priority_score >= 6 THEN 'ðŸ”µ HIGH PRIORITY - Good expression + some druggability'
        WHEN max_priority_score >= 4 THEN 'ðŸŸ¡ MEDIUM PRIORITY - Moderate expression or druggability'
        WHEN max_priority_score >= 2 THEN 'âšª LOW PRIORITY - Weak signals'
        ELSE 'MINIMAL PRIORITY'
    END as clinical_recommendation,
    CASE
        WHEN druggable_variants > 0 AND max_expression_fold > 3.0
        THEN 'ðŸ’Š HIGH-PRIORITY DRUG TARGET (Strong expression + drugs available)'
        WHEN druggable_variants > 0
        THEN 'ðŸ’Š DRUG TARGET (Multiple variants: ' || druggable_variants || '/' || transcript_variants || ')'
        WHEN max_expression_fold > 3.0
        THEN 'ðŸ”¬ RESEARCH TARGET (High expression, needs drug development)'
        ELSE 'ðŸ“Š PATHWAY TARGET (Consider pathway-level intervention)'
    END as therapeutic_strategy
FROM target_prioritization
WHERE max_priority_score >= 2  -- Only meaningful targets
ORDER BY max_priority_score DESC, max_expression_fold DESC
LIMIT 20;

-- =====================================
-- SOTA Query 3: Pathway-Based Therapeutic Strategy (WITH EXPRESSION WEIGHTING)
-- =====================================
-- Clinical Rationale: Identifies dysregulated pathways using expression data for weighting
-- NOW WORKS: Expression data provides biological relevance to pathway analysis

WITH pathway_expression_analysis AS (
    SELECT
        unnest(pathways) as pathway_name,
        COUNT(*) as total_genes,
        COUNT(DISTINCT gene_symbol) as unique_genes,
        -- Expression-based metrics
        COUNT(*) FILTER (WHERE expression_fold_change > 2.0) as highly_upregulated,
        COUNT(*) FILTER (WHERE expression_fold_change > 1.5) as upregulated_genes,
        COUNT(*) FILTER (WHERE expression_fold_change < 0.7) as downregulated_genes,
        COUNT(*) FILTER (WHERE expression_fold_change < 0.5) as highly_downregulated,
        AVG(expression_fold_change) as avg_pathway_expression,
        COUNT(*) FILTER (WHERE drugs != '{}') as druggable_genes,
        COUNT(*) FILTER (WHERE array_length(molecular_functions, 1) > 3) as functionally_diverse_genes,
        ARRAY_AGG(DISTINCT gene_symbol ORDER BY expression_fold_change DESC) as involved_genes
    FROM cancer_transcript_base
    WHERE pathways IS NOT NULL
        AND array_length(pathways, 1) > 0
        AND expression_fold_change != 1.0  -- Only genes with expression changes
    GROUP BY pathway_name
    HAVING COUNT(*) >= 3  -- At least 3 genes with expression changes
),
pathway_scoring AS (
    SELECT *,
        CASE
            -- Pathway classification
            WHEN pathway_name ILIKE '%PI3K%' OR pathway_name ILIKE '%AKT%' OR pathway_name ILIKE '%mTOR%' THEN 'growth_survival'
            WHEN pathway_name ILIKE '%RAS%' OR pathway_name ILIKE '%MAPK%' OR pathway_name ILIKE '%ERK%' THEN 'proliferation'
            WHEN pathway_name ILIKE '%p53%' OR pathway_name ILIKE '%DNA repair%' OR pathway_name ILIKE '%checkpoint%' THEN 'genome_stability'
            WHEN pathway_name ILIKE '%apoptosis%' OR pathway_name ILIKE '%cell death%' THEN 'apoptosis'
            WHEN pathway_name ILIKE '%angiogenesis%' OR pathway_name ILIKE '%VEGF%' THEN 'angiogenesis'
            WHEN pathway_name ILIKE '%immune%' OR pathway_name ILIKE '%interferon%' THEN 'immune_response'
            WHEN pathway_name ILIKE '%metabolism%' OR pathway_name ILIKE '%glycolysis%' THEN 'metabolism'
            ELSE 'other'
        END as pathway_category,
        -- Expression-weighted dysregulation score
        (highly_upregulated * 3) +  -- Highly upregulated genes (most important)
        (upregulated_genes * 2) +   -- Moderately upregulated
        (highly_downregulated * 2) + -- Highly downregulated (loss of function)
        (downregulated_genes * 1) +  -- Moderately downregulated
        (druggable_genes * 3) +      -- Druggability bonus
        (functionally_diverse_genes * 1) as dysregulation_score,
        -- Expression pattern classification
        CASE
            WHEN highly_upregulated > 0 AND highly_downregulated > 0 THEN 'mixed_dysregulation'
            WHEN highly_upregulated > upregulated_genes/2 THEN 'activation_pattern'
            WHEN highly_downregulated > downregulated_genes/2 THEN 'suppression_pattern'
            ELSE 'moderate_changes'
        END as expression_pattern
    FROM pathway_expression_analysis
)
SELECT
    pathway_category,
    pathway_name,
    unique_genes,
    highly_upregulated,
    upregulated_genes,
    downregulated_genes,
    highly_downregulated,
    ROUND(avg_pathway_expression::numeric, 2) as avg_expression,
    druggable_genes,
    dysregulation_score,
    expression_pattern,
    CASE
        WHEN dysregulation_score > 20 THEN 'ðŸš¨ CRITICAL PATHWAY - Immediate multi-target intervention'
        WHEN dysregulation_score > 12 THEN 'ðŸ”´ HIGH PRIORITY - Major pathway dysregulation detected'
        WHEN dysregulation_score > 8 THEN 'ðŸŸ¡ MODERATE PRIORITY - Significant pathway changes'
        WHEN dysregulation_score > 4 THEN 'âšª LOW PRIORITY - Minor pathway alterations'
        ELSE 'MINIMAL DYSREGULATION'
    END as intervention_priority,
    CASE
        WHEN expression_pattern = 'activation_pattern' AND druggable_genes > 2
        THEN 'ðŸ’Š PATHWAY INHIBITION - Multiple drug targets available for activated pathway'
        WHEN expression_pattern = 'suppression_pattern' AND pathway_category = 'tumor_suppressor'
        THEN 'ðŸ§¬ PATHWAY RESTORATION - Consider synthetic lethality or pathway bypass'
        WHEN expression_pattern = 'mixed_dysregulation'
        THEN 'âš–ï¸ COMPLEX TARGETING - Mixed signals require precision approach'
        WHEN druggable_genes > 0
        THEN 'ðŸŽ¯ TARGETED THERAPY - Focus on druggable components'
        ELSE 'ðŸ”¬ RESEARCH NEEDED - Pathway disrupted but lacks drug targets'
    END as therapeutic_strategy,
    involved_genes[1:5] as top_dysregulated_genes  -- Show most dysregulated genes
FROM pathway_scoring
WHERE dysregulation_score > 4  -- Only pathways with meaningful dysregulation
ORDER BY dysregulation_score DESC, avg_pathway_expression DESC
LIMIT 15;

-- =====================================
-- SOTA Query 4: Patient-Specific Expression Pattern Analysis (NEW)
-- =====================================
-- Clinical Rationale: Analyze overall expression patterns for personalized insights
-- NEW: Leverages patient-specific fold-change data for comprehensive profiling

WITH expression_profile AS (
    SELECT
        -- Overall expression statistics
        COUNT(*) as total_genes_with_changes,
        COUNT(*) FILTER (WHERE expression_fold_change > 2.0) as highly_upregulated,
        COUNT(*) FILTER (WHERE expression_fold_change BETWEEN 1.5 AND 2.0) as moderately_upregulated,
        COUNT(*) FILTER (WHERE expression_fold_change BETWEEN 0.7 AND 1.5) as normal_expression,
        COUNT(*) FILTER (WHERE expression_fold_change BETWEEN 0.5 AND 0.7) as moderately_downregulated,
        COUNT(*) FILTER (WHERE expression_fold_change < 0.5) as highly_downregulated,

        -- Therapeutic categories
        COUNT(*) FILTER (WHERE drugs != '{}' AND expression_fold_change > 1.5) as upregulated_drug_targets,
        COUNT(*) FILTER (WHERE 'kinase' = ANY(product_type) AND expression_fold_change > 1.5) as upregulated_kinases,
        COUNT(*) FILTER (WHERE 'receptor' = ANY(product_type) AND expression_fold_change > 1.5) as upregulated_receptors,

        -- Expression statistics
        MAX(expression_fold_change) as max_upregulation,
        MIN(expression_fold_change) as max_downregulation,
        AVG(expression_fold_change) as mean_expression,
        percentile_cont(0.9) WITHIN GROUP (ORDER BY expression_fold_change) as ninetieth_percentile,
        percentile_cont(0.1) WITHIN GROUP (ORDER BY expression_fold_change) as tenth_percentile
    FROM cancer_transcript_base
    WHERE expression_fold_change != 1.0  -- Only genes with expression changes
),
top_candidates AS (
    SELECT
        'Most Upregulated' as category,
        gene_symbol,
        ROUND(expression_fold_change::numeric, 2) as fold_change,
        CASE WHEN drugs != '{}' THEN 'ðŸ’Š Druggable' ELSE 'ðŸ”¬ Research' END as druggability,
        array_length(pathways, 1) as pathway_count
    FROM cancer_transcript_base
    WHERE expression_fold_change > 3.0
    ORDER BY expression_fold_change DESC
    LIMIT 5

    UNION ALL

    SELECT
        'Most Downregulated' as category,
        gene_symbol,
        ROUND(expression_fold_change::numeric, 2) as fold_change,
        CASE
            WHEN gene_symbol IN ('TP53', 'BRCA1', 'BRCA2', 'PTEN', 'ATM') THEN 'ðŸš¨ Tumor Suppressor Loss'
            WHEN drugs != '{}' THEN 'ðŸ’Š Restoration Target'
            ELSE 'ðŸ”¬ Research'
        END as druggability,
        array_length(pathways, 1) as pathway_count
    FROM cancer_transcript_base
    WHERE expression_fold_change < 0.3
    ORDER BY expression_fold_change ASC
    LIMIT 5
)
SELECT
    '=== PATIENT EXPRESSION PROFILE SUMMARY ===' as analysis_section,
    NULL as category, NULL as gene_symbol, NULL as fold_change, NULL as druggability, NULL as pathway_count
FROM expression_profile
LIMIT 1

UNION ALL

SELECT
    'Total Genes with Expression Changes: ' || total_genes_with_changes::text as analysis_section,
    NULL, NULL, NULL, NULL, NULL
FROM expression_profile

UNION ALL

SELECT
    'ðŸ”´ Highly Upregulated (>2.0x): ' || highly_upregulated::text as analysis_section,
    NULL, NULL, NULL, NULL, NULL
FROM expression_profile

UNION ALL

SELECT
    'ðŸŸ¡ Moderately Upregulated (1.5-2.0x): ' || moderately_upregulated::text as analysis_section,
    NULL, NULL, NULL, NULL, NULL
FROM expression_profile

UNION ALL

SELECT
    'ðŸ”µ Moderately Downregulated (0.5-0.7x): ' || moderately_downregulated::text as analysis_section,
    NULL, NULL, NULL, NULL, NULL
FROM expression_profile

UNION ALL

SELECT
    'ðŸ”´ Highly Downregulated (<0.5x): ' || highly_downregulated::text as analysis_section,
    NULL, NULL, NULL, NULL, NULL
FROM expression_profile

UNION ALL

SELECT
    'ðŸ’Š Upregulated Drug Targets: ' || upregulated_drug_targets::text as analysis_section,
    NULL, NULL, NULL, NULL, NULL
FROM expression_profile

UNION ALL

SELECT
    'ðŸŽ¯ Upregulated Kinases: ' || upregulated_kinases::text as analysis_section,
    NULL, NULL, NULL, NULL, NULL
FROM expression_profile

UNION ALL

SELECT
    'ðŸ“¡ Upregulated Receptors: ' || upregulated_receptors::text as analysis_section,
    NULL, NULL, NULL, NULL, NULL
FROM expression_profile

UNION ALL

SELECT
    '=== TOP EXPRESSION CANDIDATES ===' as analysis_section,
    NULL, NULL, NULL, NULL, NULL
FROM expression_profile
LIMIT 1

UNION ALL

SELECT
    NULL as analysis_section,
    category,
    gene_symbol,
    fold_change,
    druggability,
    pathway_count
FROM top_candidates
ORDER BY category DESC, fold_change DESC;

-- =====================================
-- Quick Patient Database Validation Query
-- =====================================
-- Use this to quickly validate your patient database has expression data

SELECT
    'Database Validation Results' as check_type,
    COUNT(*) as total_transcripts,
    COUNT(*) FILTER (WHERE expression_fold_change != 1.0) as transcripts_with_expression_data,
    ROUND((COUNT(*) FILTER (WHERE expression_fold_change != 1.0)::float / COUNT(*) * 100), 1) as percentage_with_data,
    MIN(expression_fold_change) as min_expression,
    MAX(expression_fold_change) as max_expression
FROM cancer_transcript_base;

-- =====================================
-- Connection Examples for All Demo Databases
-- =====================================
/*
-- Breast HER2-Positive Cancer:
PGPASSWORD=mbase_secret psql -h localhost -p 5435 -U mbase_user -d mediabase_patient_DEMO_BREAST_HER2

-- Breast Triple-Negative Cancer:
PGPASSWORD=mbase_secret psql -h localhost -p 5435 -U mbase_user -d mediabase_patient_DEMO_BREAST_TNBC

-- Lung EGFR-Mutant Adenocarcinoma:
PGPASSWORD=mbase_secret psql -h localhost -p 5435 -U mbase_user -d mediabase_patient_DEMO_LUNG_EGFR

-- Colorectal MSI-High Cancer:
PGPASSWORD=mbase_secret psql -h localhost -p 5435 -U mbase_user -d mediabase_patient_DEMO_COLORECTAL_MSI

-- Pancreatic Ductal Adenocarcinoma:
PGPASSWORD=mbase_secret psql -h localhost -p 5435 -U mbase_user -d mediabase_patient_DEMO_PANCREATIC_PDAC

-- Comprehensive Pan-Cancer:
PGPASSWORD=mbase_secret psql -h localhost -p 5435 -U mbase_user -d mediabase_patient_DEMO_COMPREHENSIVE
*/